Skip to main content
SpringerLink
Log in

Genetic Counseling for Inherited Forms of Kidney Cancer

  • Chapter
Renal Cell Cancer

  • 1010 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Reuter, V. E. and Presti, J. C. Contemporary approach to the classification of renal epithelial tumors, Semin Oncol 27: 124–137, 2000.

    PubMed  CAS  Google Scholar 

  2. Melmon, K. and Rosen, S. Lindau’s disease, Am J Med. 36: 595–617, 1964.

    Article  PubMed  CAS  Google Scholar 

  3. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D.-S. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Pasiler, D. L., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene, Science. 260: 1317–1320, 1993.

    Article  PubMed  CAS  Google Scholar 

  4. Chen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., Green, J., Hsia, Y. E., Lamiell, J., Ming, H. W., Schmidt, L., Kalman, T., Kuzmin, I., Stackhouse, T., Latif, F., Linehan, W. M., Lerman, M., and Zbar, B. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype, Hum Mutat 5: 66–75, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Crossey, P. A., Richards, F. M., Foster, K., Green, J. S., Prowse, A., Latif, F., Lerman, M. I., Zbar, B., Affara, N. A., Ferguson-Smith, M. A., and Maher, E. R. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype, Hum Mol Gen 3: 1303–1308, 1994.

    Article  PubMed  CAS  Google Scholar 

  6. Maher, E., Webster, A., Richards, F., Green, J., Crossey, P., Payne, S., and Moore, A. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations, J Med Genet 33: 328–332, 1996.

    Article  PubMed  CAS  Google Scholar 

  7. Stolle, C., Glenn, G., Zbar, B., Humphrey, J., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., and Linehan, W. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene., Hum Mutat 12: 417–423, 1998.

    Article  PubMed  CAS  Google Scholar 

  8. European Consortium on Tuberous Sclerosis: Identification and characterization of the tuberous sclerosis gene on chromosome 16, Cell. 75: 1305–1315, 1993.

    Google Scholar 

  9. van Slegtenhorst, E. A. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34, Science. 277: 805–808, 1997.

    Article  PubMed  Google Scholar 

  10. Niida, Y., Lawrence-Smith, N., Banwell, A., Hammer, E., Lewis, J., Beauchamp, R. L., Sims, K., Ramesh, V., and Ozelius, L. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis, Hum Mutat. 14: 412–422, 1999.

    Article  PubMed  CAS  Google Scholar 

  11. Roach, E. S., Gomez, M. R., and Northurp, H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria, J Child Neurol. 13: 624–628, 1988.

    Google Scholar 

  12. Roach, E. S., DiMario, F. J., and Northurp, H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation, J Child Neurol. 14: 401–407, 1998.

    Article  Google Scholar 

  13. Zimmer-Galler, I. E. and Robertson, D. M. Long-term observation of retinal lesions in tuberous sclerosis, Am J Ophthalmol. 119: 318–324, 1995.

    PubMed  CAS  Google Scholar 

  14. Ewalt, D. H., Sheffield, E., Sparagana, S. P., Delgado, M. R., and Roach, E. S. Renal lesion growth in children with tuberous sclerosis complex, J Urol. 160(1): 141–145, 1998.

    Article  PubMed  CAS  Google Scholar 

  15. Al-Saleem, T., Wessner, L. L., Scheithauer, B. W., Patterson, K., Roach, E. S., Dreyer, S. J., Fujikawa, K., Bjornsson, J., Bernstein, J., and Henske, E. P. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex, Cancer. 83: 2208–2216, 1998.

    Article  PubMed  CAS  Google Scholar 

  16. Martignoni, G., Bonetti, F., Pea, M., Tardanico, R., Brunelli, M., and Eble, J. N. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome, Am J Surg Pathol. 26: 198–205, 2002.

    Article  PubMed  Google Scholar 

  17. Siegel, D. H. and Howard, R. Molecular advances in genetic skin diseases, Curr Opin Pediatr. 14: 419–425, 2002.

    Article  PubMed  Google Scholar 

  18. Pacheco-Rodriguez, G., Kristof, A. S., Stevens, L. A., Zhang, Y., Crooks, D., and Moss, J. Giles F. Filley Lecture: Genetics and gene expression in lymphangioleiomyomatosis, Chest. 121: 56S–60S, 2002.

    Article  PubMed  Google Scholar 

  19. Yeung, R. S., Xiao, G.-H., Jin, F., Lee, W.-C., Testa, J. R., and Knudson, A. G. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene, Proc Natl Acad Sci USA. 91: 11413–11416, 1994.

    Article  PubMed  CAS  Google Scholar 

  20. Rennebeck, G., Kleymenova, E. V., Anderson, R., Yeung, R. S., Artzt, K., and Walker, C. L. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development, Proc Natl Acad Sci USA. 95: 15629–15634, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Ito, N. and Rubin, G. M. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle, Cell. 96: 529–539, 1999.

    Article  PubMed  CAS  Google Scholar 

  22. Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., and Hariharan, I. K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation, Cell. 105: 345–355, 2001.

    Article  PubMed  CAS  Google Scholar 

  23. MacCollin, M. and Kwiatkowski, D. Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1, Curr Opin Neurol. 14: 163–169, 2001.

    Article  PubMed  CAS  Google Scholar 

  24. Kwiatkowska, J., Wigowska-Sowinska, J., Napierala, D., Slomski, R., and Kwiatkowski, D. J. Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis, N Engl J Med. 340: 703–707, 1999.

    Article  PubMed  CAS  Google Scholar 

  25. Rose, V. M., Au, K. S., Pollom, G., Roach, E. S., Prashner, H. R., and Northrup, H. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet. 64: 986–992, 1999.

    Article  PubMed  CAS  Google Scholar 

  26. Brook-Carter, P. T., Peral, B., Ward, C., et al. Deletion of the TSC2 and PKD1 gene associated with severe infantile polycystic kidney disease—-A contiguous gene syndrome, Nat Genet. 8: 328–332, 1994.

    Article  PubMed  CAS  Google Scholar 

  27. Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y. S., Reeve, M. P., Thiele, E., Egelhoff, J. C., Kasprzyk-Obara, J., Domanska-Pakiela, D., and Kwiatkowski, D. J. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs, Am J Hum Genet. 68: 64–80, 2001.

    Article  PubMed  CAS  Google Scholar 

  28. Langkau, N., Martin, N., Brandt, R., Zugge, K., Quast, S., Wiegele, G., Jauch, A., Rehm, M., Kuhl, A., Mack-Vette, r. M., Zimmerhackl, B., and Janssen, B. TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1/ TSC2 frequency ratios, Eur J Pediatr. 161: 393–402, 2002.

    Google Scholar 

  29. Van Slegtenhorst, M., Nellist, M., Nagelkerken, B., Cheadle, J., Snell, R., van den Ouweland, A., Reuser, A., Sampson, J. P., Halley, D., and Sluijs, P. Interaction between hamartin and tuberin, TSC1 and TSC2 gene products, Hum Mol Genet. 7: 1053–1057, 1998.

    Article  PubMed  Google Scholar 

  30. Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O., and Noda, T. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice, Cancer Res. 59: 1206–1211, 1999.

    PubMed  CAS  Google Scholar 

  31. Onda, H., Lueck, A., Marks, P. W., Warren, H. B., and Kwiatkowski, D. J. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background, J Clin Invest. 104: 687–695, 1999.

    Article  PubMed  CAS  Google Scholar 

  32. Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H., Kobayashi, E., Noda, T., and Hino, O. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice, Proc Natl Acad Sci USA. 98: 8762–8767, 2001.

    Article  PubMed  CAS  Google Scholar 

  33. Green, A. J., Smith, M., and Yates, J. R. W. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients, Nat Genet. 6: 192–196, 1994.

    Article  Google Scholar 

  34. Sepp, T., Yates, J. R., and Green, A. J. Loss of heterozygosity in tuberous sclerosis hamartomas, J Med Genet. 33: 962–964, 1996.

    PubMed  CAS  Google Scholar 

  35. Henske, E. P., Neumann, H. P., Scheithauer, B. W., Herbst, E. W., Short, M. P., and Kwiatkowski, D. J. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas, Gene Chromosomes Cancer. 13: 295–298, 1995.

    Article  CAS  Google Scholar 

  36. Carsillo, T., Astrinidis, A., and Henske, E. P. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis, Proc Natl Acad Sci USA. 97: 6085–6090, 2000.

    Article  PubMed  CAS  Google Scholar 

  37. Henske, E. P., Neumann, H. P., Scheithauer, B. W., Herbst, E. W., Short, M. P., and Kwiatkowski, D. J. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas, Genes Chromosomes Cancer. 13: 295–298, 1995.

    Article  PubMed  CAS  Google Scholar 

  38. Jin, F., Wienecke, R., Xiao, G. H., Maize, J. C., DeClue, J. E., and Yeung, R. S. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region., Proc Natl Acad Sci USA. 93: 9154–9159, 1996.

    Article  PubMed  CAS  Google Scholar 

  39. Potter, C. J., Pedraza, L. G., and Xu, T. Akt regulates growth by directly phosphorylating Tsc2, Nat Cell Biol. 4: 658–665, 2002.

    Article  PubMed  CAS  Google Scholar 

  40. Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S., Ru, B., and Pan, D. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling, Nat Cell Biol. 4: 699–704, 2002.

    Article  PubMed  CAS  Google Scholar 

  41. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat Cell Biol. 4: 648–657, 2002.

    Article  PubMed  CAS  Google Scholar 

  42. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., and Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway, Mol Cell. 10: 151–162, 2002.

    Article  PubMed  CAS  Google Scholar 

  43. Hay, N. The Akt-mTOR tango and its relevance to cancer, Cancer Cell. 8: 179–183, 2005.

    Article  PubMed  CAS  Google Scholar 

  44. Kovacs, G., Brusa, P., and De Riese, W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas, Int J Cancer. 43: 422–427, 1989.

    Article  PubMed  CAS  Google Scholar 

  45. Bodmer, D., Eleveld, M. J., Ligtenberg, M. J., Weterman, M. A., Janssen, B. A., Smeets, D. F., de Wit, P. E., van den Berg, A., van den Berg, E., Koolen, M. I., and Geurts van Kessel, A. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation, Am J Hum Genet. 62(6): 1475–1483, 1998.

    Article  PubMed  CAS  Google Scholar 

  46. Bodmer, D., Eleveld, M., Ligtenberg, M., Weterman, M., van der Meijden, A., Koolen, M., Hulsbergen-van der Kaa, C., Smits A, S. D., and Geurts van Kessel, A. Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21), Cancer Genet Cytogenet. 134: 6–12, 2002.

    Article  PubMed  CAS  Google Scholar 

  47. Podolski, J., Byrski, T., Zajaczek, S., Druck, T., Zimonjic, D. B., Popescu, N. C., Kata, G., Borowka, A., Gronwald, J., Lubinski, J., and Huebne, R. K. Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation, J Hum Genet. 46: 685–693, 2001.

    Article  PubMed  CAS  Google Scholar 

  48. Li, F. P., Decker, H. J., Zbar, B., Stanton, V. P., Kovacs, G., Seizinger, B. R., Aburatani, H., Sandberg, A. A., Berg, S., Hosoe, S., et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation, Ann Intern Med. 118: 106–111, 1993.

    PubMed  CAS  Google Scholar 

  49. Schmidt, L., Li, F., Brown, R. S., Berg, S., Chen, F., Wei, M. H., Tory, K., Lerman, M. I., and Zbar, B. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation, Cancer J Sci Am. 1: 191, 1995.

    PubMed  CAS  Google Scholar 

  50. Eleveld, M. J., Bodmer, D., Merkx, G., Siepman, A., Sprenger, S. H., Weterman, M. A., Ligtenberg, M. J., Kamp, J., Stapper, W., Jeuken, J. W., Smeets, D., Smits, A., and Geurts Van Kessel, A. Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15), Genes Chromosomes Cancer. 31: 23–32, 2001.

    Article  PubMed  CAS  Google Scholar 

  51. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck T, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers, Cell. 84: 587–597, 1996.

    Article  PubMed  CAS  Google Scholar 

  52. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity, Proc Natl Acad Sci USA. 94: 13771–13776, 1997.

    Article  PubMed  CAS  Google Scholar 

  53. Fong, L. Y., Fidanza, V., Zanesi, N., Lock, L. F., Siracusa, L. D., Mancini, R., Siprashvili, Z., Ottey, M., Martin, S. E., Druck, T., McCue, P., Croce, C. M., and Huebner, K. Muir-Torre-like syndrome in Fhit-deficient mice, Proc Natl Acad Sci USA. 97: 4742–4747, 2000.

    Article  PubMed  CAS  Google Scholar 

  54. Gemmill, R. M., West, J. D., Boldog, F., Tanaka, N., Robinson, L. J., Smith, D. I., Li, F., and Drabkin, H. A. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8, Proc Natl Acad Sci USA. 95: 9572–9577, 1998.

    Article  PubMed  CAS  Google Scholar 

  55. Druck, T., Podolski, J., Byrski, T., Wyrwicz, L., Zajaczek, S., Kata, G., Borowka, A., Lubinski, J., and Huebner, K. The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation, J Hum Genet. 46: 583–589, 2001.

    Article  PubMed  CAS  Google Scholar 

  56. Bodmer, D., Eleveld, M., Kater-Baats, E., Janssen, I., Janssen, B., Weterman, M., Schoenmaker, E., Nickerson, M., Linehan, M., Zbar, B., and van Kessel, A. G. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21), Hum Mol Genet. 11(6): 641–649, 2002.

    Article  PubMed  CAS  Google Scholar 

  57. Goedert, J. J., McKeen, E. A., and Fraumeni, J. F. Polymastia and renal adenocarcinoma, Ann Intern Med. 95: 182–184, 1981.

    PubMed  CAS  Google Scholar 

  58. Mehes, K. Familial association of supernumerary nipple with renal cancer, Cancer Genet Cytogenet. 86: 129–130, 1996.

    Article  PubMed  CAS  Google Scholar 

  59. Zbar, B. and Lerman, M. Inherited carcinomas of the kidney, Adv Cancer Res. 75: 163–201, 1998.

    Article  PubMed  CAS  Google Scholar 

  60. Zbar, B. Inherited epithelial tumors of the kidney: old and new disease, Semin Cancer Biol. 10: 313–318, 2000.

    Article  PubMed  CAS  Google Scholar 

  61. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. R., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T., and Zbar, B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas, Nat Genet. 16: 68–73, 1997.

    Article  PubMed  CAS  Google Scholar 

  62. Zhuang, Z., Park, W. S., Pack, S., Schmidt, L., Vortmeyer, A. O., Pak, E., Pham, T., Weil, R. J., Candidus, S., Lubensky, I. A., Linehan, W. M., Zbar, B., and Weirich, G. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas, Nat Genet. 20(1): 66–69, 1998.

    Article  PubMed  CAS  Google Scholar 

  63. Duh, F. M., Scherer, S. W., Tsui, L. C., Lerman, M. I., Zbar, B., and Schmidt, L. Gene structure of the human MET proto-oncogene, Oncogene. 15: 1583–1586, 1997.

    Article  PubMed  CAS  Google Scholar 

  64. Bardelli, A., Ponzetto, C., and Comoglio, P. M. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering, J Biotechnol. 37: 109–122, 1994.

    Article  PubMed  CAS  Google Scholar 

  65. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product, Science. 251: 802–804, 1991.

    Article  PubMed  CAS  Google Scholar 

  66. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., and Comoglio, P. M. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family, Cell. 77: 261–271, 1994.

    Article  PubMed  CAS  Google Scholar 

  67. Naldini, L., Vigna, E., Ferracini, R., Longati, P., Gandino, L., Prat, M., and Comoglio, P. M. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation, Mol Cell Biol. 4: 1793–1803, 1991.

    Google Scholar 

  68. Giordano, S., Zhen, Z., Medico, E., Gaudino, G., Galimi, F., and Comoglio, P. M. Transfer of mitogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene, Proc Natl Acad Sci USA. 90: 649–653, 1993.

    Article  PubMed  CAS  Google Scholar 

  69. Koochekpour, S., Jeffers, M., Wang, P. H., Gong, C., Taylor, G. A., Roessler, L. M., Stearman, R., Vasselli, J. R., Stetler-Stevenson, W. G., Kaelin, W. G., Linehan, W. M., Klausner, R. D., Gnarra, J. R., and Vande Woude, G. F. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells, Mol Cell Biol. 19: 5902–5912, 1999.

    PubMed  CAS  Google Scholar 

  70. Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., and Aaltonen, L. A. Inherited susceptibility to uterine leiomyomas and renal cell cancer, Proc Natl Acad Sci USA. 98: 3387–3392, 2001.

    Article  PubMed  CAS  Google Scholar 

  71. Alam, N. A., Bevan, S., Churchman, M., et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43, Am J Hum Genet. 68: 1264–1269, 2001.

    Article  PubMed  CAS  Google Scholar 

  72. Consortium, T. M. L. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nat Genet. 30: 306–310, 2002.

    Article  Google Scholar 

  73. Alam, N. A., Olpin, S., and Leigh, I. M. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer, Br J Dermatol. 153(1): 11–17, 2005.

    Article  PubMed  CAS  Google Scholar 

  74. Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y. L., Merino, M., Trepel, J., Zbar, B., Toro, J., Ratcliffe, P. J., Linehan, W. M., and Neckers, L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability, Cancer Cell. 8: 143–153, 2005.

    Article  PubMed  CAS  Google Scholar 

  75. Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C., and Gottlieb, E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase, Cancer Cell. 7: 77–85, 2005.

    Article  PubMed  CAS  Google Scholar 

  76. Malchoff, C. D., Sarfarazi, M., Tendler, B., Forouhar, F., Whalen, G., Joshi, V., Arnold, A., and Malchoff, D. M. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome, J Clin Endocrinol Metab. 85: 1758–1764, 2000.

    Article  PubMed  CAS  Google Scholar 

  77. Birt, A. R., Hogg, G. R., and Dube, W. J. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons, Arch Dermatol. 113: 1674–1677, 1977.

    Article  PubMed  CAS  Google Scholar 

  78. Scalvenzi, M., Argenziano, G., Sammarco, E., and Delfino, M. Hereditary multiple fibrofolliculomas, trichodiscomas and acrochordons: syndrome of Birt-Hogg-Dube, J Eur Acad Dermatol Venereol. 11: 45–47, 1998.

    PubMed  CAS  Google Scholar 

  79. Toro, J. R., Glenn, G., Duray, P., Darling, T., Weirich, G., Zbar, B., Linehan, M., and Turner, M. L. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia, Arch Dermatol. 135: 1195–1202, 1999.

    Article  PubMed  CAS  Google Scholar 

  80. Roth, J. S., Rabinowitz, A. D., Benson, M., and Grossman, M. E. Bilateral renal cell carcinoma in the Birt-Hogg-Dube syndrome, J Am Acad Dermatol. 29: 1055–1056, 1993.

    PubMed  CAS  Google Scholar 

  81. Khoo, S. K., Bradley, M., Wong, F. K., Hedblad, M. A., Nordenskjold, M., and Teh, B. T. Birt-Hogg-Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2, Oncogene. 20: 5239–5242, 2001.

    Article  PubMed  CAS  Google Scholar 

  82. Zbar, B., Alvord, W. G., Glenn, G., Turner, M., Pavlovich, C. P., Schmidt, L., Walther, M., Choyke, P., Weirich, G., Hewitt, S. M., Duray, P., Gabril, F., Greenberg, C., Merino, M. J., Toro, J., and Linehan, W. M. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome, Cancer Epidemiol Biomarkers Prev. 11: 393–400, 2002.

    PubMed  Google Scholar 

  83. Schmidt, L. S., Warren, M. B., Nickerson, M. L., Weirich, G., Matrosova, V., Toro, J. R., Turner, M. L., Duray, P., Merino, M., Hewitt, S., Pavlovich, C. P., Glenn, G., Greenberg, C. R., Linehan, W. M., and Zbar, B. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2, Am J Hum Genet. 69: 876–882, 2001.

    Article  PubMed  CAS  Google Scholar 

  84. Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., Sharma, N., Walther, M., Munroe, D., Hill, R., Maher, E., Greenberg, C., Lerman, M. I., Linehan, W. M., Zbar, B., and Schmidt, L. S. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome, Cancer Cell. 2: 157–164, 2002.

    Article  PubMed  CAS  Google Scholar 

  85. Weirich, G., Glenn, G., Junke, R. K., Merino, M., Storkel, S., Lubensky, I., Choyke, P., Pack, S., Amin, M., Walther, M. M., Lineha, W. M., and Zbar, B. Familial renal oncocytoma: clinicopathological study of 5 families, J Urol. 160: 335–340, 1998.

    Article  PubMed  CAS  Google Scholar 

  86. Leroy, X., Leteurtre, E., Mahe, P. H., Gosselin, B., Delobel, B., and Croquette, M. F. Renal oncocytoma with a novel chromosomal rearrangement, der(13)t(13;16)(p11;p11), associated with a renal cell carcinoma, J Clin Pathol. 55: 157–158, 2002.

    PubMed  CAS  Google Scholar 

  87. Bennett, R. L., Steinhaus, K. A., Uhrich, S. B., O’Sullivan, C. K., Resta, R. G., Lochner-Doyle, D., Markel, D. S., Vincent, V., and Hamanishi, J. Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors, Am J Hum Genet. 56: 745–752, 1995.

    PubMed  CAS  Google Scholar 

  88. Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., et al. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors, J Genet Couns. 13: 83–114, 2004.

    Article  PubMed  Google Scholar 

  89. Weil, J. E. Psychosocial Genetic Counseling. Oxford University Press, New York, 2002.

    Google Scholar 

  90. Simpson, J. L., Carson, S. A., and Cisneros, P. Preimplantation genetic diagnosis (PGD) heritable neoplasia, J Natl Cancer Inst Monogr. 34: 87–90, 2005.

    Article  PubMed  Google Scholar 

  91. Rechitsky, S., Verlinsky, O., Chistokhina, A., Sharapova, T., Ozen, S., Masciangelo, C., Kuliev, A., and Verlinsky, Y. Preimplantation genetic diagnosis for cancer predisposition, Reprod Biomed Online. 5: 148–155, 2002.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Peter Hulick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gayun Chan-Smutko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Zimmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Othon Iliopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Academic Medical Center University Hospital, Amsterdam, The Netherlands

    Jean J.M.C.H. de la Rosette MD,PhD (Chairman) (Chairman)

  2. Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

    Cora N. Sternberg MD,FACP (Chairman) (Chairman)

  3. Department of Urology, University Hospital of Katholieke Universiteit Leuven, Leuven, Belgium

    Hein P.A. van Poppel MD,PhD (Chairman) (Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hulick, P., Chan-Smutko, G., Zimmer, M., Iliopoulos, O. (2008). Genetic Counseling for Inherited Forms of Kidney Cancer. In: Rosette, J.J.d., Sternberg, C.N., Poppel, H.P.v. (eds) Renal Cell Cancer. Springer, London. https://doi.org/10.1007/978-1-84628-763-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-763-3_15

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-385-7

  • Online ISBN: 978-1-84628-763-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation